Our Mission

”We develop Surface Plasmon Resonance (SPR) technology beyond today’s capabilities. We stay ahead of the latest developments to bring the best to the market. We manufacture MP-SPR instruments with superior features and performance.”

MP-SPR Navi™

MP-SPR Navi™ has been developed in collaboration with Dr. Janusz Sadowski who has been the main driver in the research of SPR technique at VTT for over 20 years, and Dr. Ulf Jönsson, the founder and former CEO of Biacore, the company that pioneered the use of SPR spectroscopy for protein interaction analysis.

Collaboration

We are committed to bringing the best surface measurement solutions to the market. We are open to new ideas and therefore, work on new applications and technologies with a number of companies and research groups. If you want us to collaborate with you on a project, please contact us.

History of BioNavis

1988 – VTT (Technical Research Centre of Finland) commences research on surface plasmon resonance, Dr. Janusz Sadowski (now VP R&D of BioNavis)

2006 – BioNavis Ltd is established as a privately held company and utilizes KSV Instruments Ltd. for distribution, which was later acquired by Biolin Scientific AB

2008 – The first SPR Navi™ 200 (open and modular) instrument is introduced to the market together with gold sensor slides.

2010 – BioNavis centralizes the management of the distribution network to its headquarters in Finland (about 40 distributors worldwide)

2011 – Multi-Parametric Surface Plasmon Resonance (MP-SPR) is introduced to the market. BioNavis offers a new fully automated SPR Navi™ 220A (well-plate automation) instrument intended for Life Sciences. For the first time, commercial SPR instruments are available with multiple wavelengths. The sensor slide range is extended extensively with Ag, Pt, Cu, Al, TiO2, SiO2, CMD, Ni2+ etc.

2012 - BioNavis brings SPR Navi™ 210A (6-sample automation) model to the Material Science market. Also novel technique Selectively Amplified SPR is introduced for signal enhancement of tricky assay. Dramatic increase in order intake.

2013 - SPR Navi™ introduces an extensive range of flow-cells dedicated to specific application. For the first time commercial SPR instrument succeeds to measure transcellular and paracellular drug-cell interactions label-free.

2014 - BioNavis Ltd appoints new CEO, Dr. Johana Kuncová-Kallio. The growth in double digits continues.

2015 - BioNavis introduces new generation of MP-SPR Navi™ instruments: 200 OTSO, 210A VASA, 220A NAALI and a completely new 4-channel instrument 420A ILVES.

2016 - BioNavis celebrates 10 years in the market!

2018 - Introduction of 400 KONTIO instrument dedicated to live cell measurement. Development of regenerable avidin kit.

2020 - MP-SPR Navi™ instrument family is completed with 4-channel 410A KAURIS instrument.